The Neurobiology of Attention-Deficit/Hyperactivity Disorder

Samuel R. Chamberlain,Trevor W. Robbins,Barbara J. Sahakian
DOI: https://doi.org/10.1016/j.biopsych.2007.04.009
IF: 12.81
2007-01-01
Biological Psychiatry
Abstract:This special issue of Biological Psychiatry focuses on attention-deficit/hyperactivity disorder (ADHD), a highly heritable and disabling condition characterized by core behavioral symptoms of impulsivity, hyperactivity, and/or inattention ( 1 American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. American Psychiatric Press, Washington, DC1994 Google Scholar ). Attention-deficit/hyperactivity disorder is the most prevalent neuropsychiatric disorder of childhood with a prevalence of 4% to 10%. It is often overlooked that some 40% to 60% of these children will still show clinically significant symptoms into adulthood. Attention-deficit/hyperactivity disorder should not be seen as an absolute bar to academic and social success. However, it has been associated with educational difficulties, increased criminality, substance abuse, family breakups, and driving accidents. The excess cost of the condition (in terms of education, occupational impairment, and medical treatment) was estimated at $30 billion in the United States in 2000 ( 2 Birnbaum H.G. Kessler R.C. Lowe S.W. Secnik K. Greenberg P.E. Leong S.A. et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: Excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005; 21: 195-206 Crossref PubMed Scopus (189) Google Scholar ). Given the disabling and prevalent nature of ADHD, it is important to further our understanding of the neural underpinnings of this condition and the mechanisms by which drug treatments exert their beneficial effects.
What problem does this paper attempt to address?